Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential
Authors:
Open Access
- 15 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-16
Abstract
Cardiac cellular fate transition holds remarkable promise for the treatment of ischemic heart disease. We report that overexpressing two transcription factors, Sall4 and Gata4, which play distinct and overlapping roles in both pluripotent stem cell reprogramming and embryonic heart development, induces a fraction of stem-like cells in rodent cardiac fibroblasts that exhibit unlimited ex vivo expandability with clonogenicity. Transcriptomic and phenotypic analyses reveal that around 32 ± 6.4% of the expanding cells express Nkx2.5, while 13 ± 3.6% express Oct4. Activated signaling pathways like PI3K/Akt, Hippo, Wnt, and multiple epigenetic modification enzymes are also detected. Under suitable conditions, these cells demonstrate a high susceptibility to differentiating into cardiomyocyte, endothelial cell, and extracardiac neuron-like cells. The presence of partially pluripotent-like cells is characterized by alkaline phosphatase staining, germ layer marker expression, and tumor formation in injected mice (n = 5). Additionally, significant stem-like fate transitions and cardiogenic abilities are induced in human cardiac fibroblasts, but not in rat or human skin fibroblasts. Molecularly, we identify that SALL4 and GATA4 physically interact and synergistically stimulate the promoters of pluripotency genes but repress fibrogenic gene, which correlates with a primitive transition process. Together, this study uncovers a new cardiac regenerative mechanism that could potentially advance therapeutic endeavors and tissue engineering.Keywords
This publication has 69 references indexed in Scilit:
- Robust small molecule-aided cardiac reprogramming systems selective to cardiac fibroblastsiScience, 2023
- Epigenetic rejuvenation by partial reprogrammingBioEssays, 2023
- In vivo partial cellular reprogramming enhances liver plasticity and regenerationCell Reports, 2022
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- Reduction of Fibrosis and Scar Formation by Partial Reprogramming In VivoStem Cells, 2018
- Direct Cardiac Cellular Reprogramming for Cardiac RegenerationCurrent Treatment Options in Cardiovascular Medicine, 2016
- Nerves Regulate Cardiomyocyte Proliferation and Heart RegenerationDevelopmental Cell, 2015
- Transcription Factor Pathways and Congenital Heart Disease2012
- Distinguishing Between Mouse and Human Pluripotent Stem Cell Regulation: The Best Laid Plans of Mice and MenStem Cells, 2010
- Multipotent Embryonic Isl1+ Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell DiversificationCell, 2006